3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
4
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Recurrence
1
Pinealoma
1
Pancreatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Locally Advanced Rectal Adenocarcinoma
1
Locally Advanced Cervical Carcinoma
1
Liver Neoplasms
1
Liver Diseases
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gastric Cancer With Liver Metastases
1
Endometrial Neoplasms
1
Digestive System Neoplasms
1
Interventions
Gemcitabine
8
Cisplatin
8
pembrolizumab
4
durvalumab
4
Specimen Handling
3
Platinum
3
Oxaliplatin
3
Leucovorin
3
1,2-diaminocyclohexaneplatinum II citrate
3
Taxes
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Folfox protocol
2
Fluorouracil
2
Biopsy
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
zanidatamab
1
trastuzumab deruxtecan
1
tivozanib
1
peposertib
1
guadecitabine
1
fludarabine
1
dehydroftorafur
1
binimetinib
1
avelumab
1
atezolizumab
1
Trastuzumab
1
Radiation Dose Hypofractionation
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Immunotherapy
×
90 days
×
Clear all
No trials found.